Boston Scientific (HAM:BSX) Cyclically Adjusted Book per Share: €10.35 (As of Mar. 2026)


HAM:BSX Boston Scientific Corp HAM:BSX
74 GF Score
Price €39.79
GF Value €91.81
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Cyclically Adjusted Book per Share?

Boston Scientific HAM:BSX +0.32% 74 Cyclically Adjusted Book per Share is €10.35 as of Mar. 2026. GuruFocus rates HAM:BSX with a GF Score™ of 74/100 and a GF Value™ of €91.81 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Boston Scientific's adjusted book value per share for the three months ended in Mar. 2026 was €15.052. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €10.35 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Boston Scientific's average Cyclically Adjusted Book Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Boston Scientific was 25.70% per year. The lowest was -6.70% per year. And the median was 10.80% per year.

As of today (2026-07-07), Boston Scientific's current stock price is €39.79. Boston Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €10.35. Boston Scientific's Cyclically Adjusted PB Ratio of today is 3.84.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boston Scientific was 10.37. The lowest was 2.65. And the median was 5.82.


Boston Scientific  (HAM:BSX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Boston Scientific's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=39.79/10.35
=3.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boston Scientific was 10.37. The lowest was 2.65. And the median was 5.82.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Boston Scientific Cyclically Adjusted Book per Share Related Terms


Boston Scientific Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Cyclically Adjusted Book per Share Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 9.72

Boston Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 9.72 10.35

HAM:BSX vs EW, GEHC, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted PB Ratio falls into.


HAM:BSX
74GF Score
Boston Scientific Corp HAM:BSX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boston Scientific's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=15.052/330.2130*330.2130
=15.052

Current CPI (Mar. 2026) = 330.2130.

Boston Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201606 4.074 241.018 5.582
201609 4.242 241.428 5.802
201612 4.686 241.432 6.409
201703 4.817 243.801 6.524
201706 4.699 244.955 6.335
201709 4.638 246.819 6.205
201712 4.313 246.524 5.777
201803 4.132 249.554 5.468
201806 4.799 251.989 6.289
201809 5.134 252.439 6.716
201812 5.539 251.233 7.280
201903 5.875 254.202 7.632
201906 5.994 256.143 7.727
201909 6.318 256.759 8.125
201912 8.953 256.974 11.505
202003 8.928 258.115 11.422
202006 9.703 257.797 12.429
202009 9.228 260.280 11.707
202012 8.894 260.474 11.275
202103 9.295 264.877 11.588
202106 9.307 271.696 11.312
202109 9.821 274.310 11.822
202112 10.320 278.802 12.223
202203 10.630 287.504 12.209
202206 11.414 296.311 12.720
202209 12.441 296.808 13.841
202212 11.574 296.797 12.877
202303 11.598 301.836 12.688
202306 11.501 305.109 12.447
202309 12.080 307.789 12.960
202312 12.063 306.746 12.986
202403 12.470 312.332 13.184
202406 12.865 314.175 13.522
202409 12.663 315.301 13.262
202412 14.099 315.605 14.752
202503 13.890 319.799 14.342
202506 13.130 322.561 13.441
202509 13.447 324.800 13.671
202512 13.954 324.054 14.219
202603 15.052 330.213 15.052

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €10.35 mean?
Boston Scientific (HAM:BSX) has a Cyclically Adjusted Book per Share of €10.35 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Cyclically Adjusted Book per Share too high?
Boston Scientific's current Cyclically Adjusted Book per Share is €10.35. Overall, Boston Scientific has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Cyclically Adjusted Book per Share compare to EW and GEHC?
Boston Scientific's Cyclically Adjusted Book per Share of €10.35 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Boston Scientific and its competitors. Boston Scientific's current Cyclically Adjusted Book per Share is €10.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (HAM:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is €91.81, compared to a current price of €39.79 — trading 56.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is €10.35. Boston Scientific's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Boston Scientific (HAM:BSX), the current Cyclically Adjusted Book per Share is €10.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (HAM:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of €39.79 is trading 56.7% below its estimated GF Value™ of €91.81. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for HAM:BSX:

  • Cyclically Adjusted Book per Share: €10.35
  • GF Value™: €91.81 vs. price of €39.79 (56.7% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the HAM:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
74GF Score

Get the complete analysis for HAM:BSX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.79
Price
€91.81
GF Value